Last reviewed · How we verify

NCT06315374

3D-Printed Aerosolized Medication Delivery Assist Device in Patients With Chronic Respiratory Diseases

Withdrawn NA Last updated 4 February 2026
What this trial tests

NA trial testing Use soft mist inhaler in Chronic Pulmonary Disease. Withdrawn.

Timeline
28 March 2024
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorFu Jen Catholic University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeother
Start date28 March 2024
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Fu Jen Catholic University

Who can join

Adults 45 to 80, any sex, with Chronic Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the auxiliary benefits of three-dimensional printed activating assistive devices for soft-mist inhaler on patients' utilization habit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fu Jen Catholic University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06315374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing